United States Microbiome Sequencing Services Market to Grow with a CAGR of 7.51% through 2028
Advances in
sequencing technologies, increased awareness of microbiome health, and its
applications in personalized medicine, agriculture, and environmental sciences
is expected to drive the United States Microbiome Sequencing Services Market
growth in the forecast period, 2024-2028.
According to
TechSci Research report, “United States Microbiome Sequencing Services Market – By Region,
Competition, Forecast and Opportunities, 2028”, the United States Microbiome
Sequencing Services Market stood at USD 383.72 Million in 2022 and is anticipated
to grow with a CAGR of 7.51% in the forecast period, 2024-2028. This can be
attributed to data analysis and bioinformatics. As the volume of microbiome
data grows, the demand for advanced bioinformatics and data analysis tools has
surged. Innovations in data analysis techniques are allowing researchers to
extract meaningful insights from complex microbiome datasets, making the results
more interpretable and actionable.
In addition, the
vast amount of data generated by microbiome sequencing services requires
advanced data analysis tools. Artificial intelligence (AI) and machine learning
(ML) are increasingly being applied to microbiome data to uncover patterns,
make predictions, and identify biomarkers associated with health and disease.
These technologies are poised to revolutionize data analysis in microbiome
research.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on " United States Microbiome Sequencing Services Market”
During the
COVID-19 pandemic, extensive research focused on understanding the impact of
the SARS-CoV-2 virus on human health. Microbiome sequencing services played a
crucial role in investigating this impact, particularly on the human
microbiome. A study titled "The Distinct Influence of COVID-19 on Human
Gut Microbiome Research," published in the March 2021 issue of Frontiers
in Medicine, delves into the direct and indirect effects of the pandemic on the
gut microbiome, with implications for research and clinical trials. The study
revealed a profound interaction between the gut microbiome and the SARS-CoV-2
virus. The disrupted gut microbiome was found to contribute to the course and
severity of COVID-19, as the loss of beneficial microbes, proliferation of
potentially harmful ones, and reduced microbial diversity all worsened health
outcomes. Microbiome sequencing services played a pivotal role in this
research, enabling the study of the gut microbiome at different stages of
infection. Therefore, the increased utilization of these services during the
pandemic is expected to fuel market growth.
The growing
demand for Next-Generation Sequencing (NGS) is a significant driver of the
microbiome sequencing services market. An article titled "Bioinformatics
and Computational Tools for Clinical Genetics Analysis Using Next-Generation
Sequencing," published in the January 2020 issue of the Journal of
Clinical Medicine, highlighted how NGS had revolutionized clinical genetics by
enabling the analysis of hundreds of genes rapidly and at a lower cost compared
to conventional sequencing methods. The article also pointed out that
advancements in machine learning algorithms, such as neural networks and
support vector machines, coupled with innovations in artificial intelligence,
are contributing to the development of novel tools for integrated sequencing
system levels. These innovations in NGS services are expected to bolster the
microbiome sequencing services market's growth.
The global
upsurge in genomic research is another key factor driving growth in the
microbiome sequencing services market. According to data from the National
Human Genome Research Institute of the United States National Institute of
Health, updated in April 2022, the increasing number of biomedical research
projects and large-scale collaborations is generating a substantial amount of
genomic data, ranging from 2 to 40 billion gigabytes annually. The multitude of
research and development initiatives in genomic research is contributing to the
expansion of the microbiome sequencing services market.
Furthermore, in
June 2021, Illumina and Microba Life Sciences formed a partnership aimed at
advancing our understanding of the human gut microbiome's role in human health
and disease. This collaboration combines Illumina's cutting-edge NGS tools with
Microba's proprietary high-quality gut microbiome analysis platform to generate
precise metagenomic data crucial for researchers seeking new discoveries. Such
collaborative research ventures are also propelling market growth.
Nevertheless,
ethical and legal concerns related to genome sequencing and a shortage of
skilled technicians for NGS data analysis pose challenges to the microbiome
sequencing services market's growth in the forecast period.
The United
States Microbiome Sequencing Services Market is segmented into technology,
application, regional distribution, and company.
Based on its application,
the oncology segment has emerged as the predominant market leader. Oncology is
the dominant segment within the Microbiome Sequencing Services market. The
surge in global cancer cases and the expanding field of cancer genomics
research are anticipated to drive growth in the microbiome sequencing services
sector. An article titled "Exploring the Potential of Cancer Microbiome
Research," published in the Genome Biology journal in June 2020, delved
into the multifaceted impact of the human microbiome on various aspects of
cancer, including its initiation, progression, detection, treatment, and
prognosis. This article suggested that a considerable proportion of cancer
cases could be attributed to microbial influences, and that microbes could have
both tumor-inhibiting and tumor-promoting properties, which warrant further
investigation into the relationship between microbiomes and cancer. The
increasing number of studies investigating the microbiome's role in cancer is
fueling growth in the oncology segment of the microbiome sequencing services
market during the projected period.
The
contributions of leading market players in the sector's research and
development efforts are also contributing to market expansion. For example, in
March 2022, Microbiotica secured $67 million in funding to support its research
in microbiome-based immuno-oncology, including upcoming phase 1b trials
scheduled for later this year. Such initiatives by key market players are
anticipated to drive the market's growth.
Based on region,
the North-East region is poised to dominate the United States Microbiome
Sequencing Services Market for several compelling reasons. Firstly, the region
is home to a cluster of renowned academic and research institutions, including
Ivy League universities and world-class medical centers, which foster a culture
of innovation and scientific excellence. These institutions attract top talent
and cutting-edge research, creating a rich ecosystem for microbiome sequencing
expertise. Secondly, the North-East region benefits from proximity to major
biotech and pharmaceutical hubs such as Boston and New York City, which provide
a well-established infrastructure for biotechnology companies to thrive.
Moreover, the region's diverse and densely populated urban centers offer a vast
pool of potential customers and collaborators, making it an ideal location for
microbiome sequencing service providers to establish a strong presence. Lastly,
the North-East's commitment to healthcare innovation and robust funding
opportunities further cements its position as a dominant force in the
burgeoning microbiome sequencing services market in the United States.
Major companies
operating in United States Microbiome Sequencing Services Market are:
- BaseClear B.V.
- Clinical-Microbiomics A/S
- Merieux Nutrisciences India Pvt Ltd.
- EpiBiome, Inc.
- Microbiome Insights Inc.
- MicroBiome Therapeutics, LLC
- MR DNA
- Second Genome Inc.
- uBiome
- Zymo Research Corp
Download Free Sample Report
Customers can
also request for 10% free customization on this report.
“The United
States Microbiome Sequencing Services Market is experiencing a wave of
innovation and expansion. The upcoming key trends discussed here reflect the
diverse and evolving applications of microbiome research, from personalized
healthcare to sustainable agriculture and environmental conservation. As
technologies advance and our understanding of the microbiome deepens, the
market for microbiome sequencing services is poised for sustained growth,
offering exciting possibilities for scientific discovery and practical
applications across multiple sectors,” said Mr. Karan Chechi, Research Director
with TechSci Research, a research-based management consulting firm.
“United States Microbiome
Sequencing Services Market By Technology
(Sequencing by Ligation (SBL), Sequencing by Synthesis (SBS), Shotgun
Sequencing, Targeted Gene Sequencing, Others), By Application (Gastrointestinal
Diseases, Infectious Diseases, CNS Diseases, Oncology, Others), By Region, By Competition Forecast & Opportunities, 2018-2028F”,
has evaluated the future growth potential of United States Microbiome
Sequencing Services Market and provides statistics & information on market
size, structure and future market growth. The report intends to provide
cutting-edge market intelligence and help decision makers take sound investment
decisions. Besides, the report also identifies and analyzes the emerging trends
along with essential drivers, challenges, and opportunities in United States Microbiome
Sequencing Services Market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: www.techsciresearch.com